Real-time enrollment status for this metastatic castration-resistant prostate cancer clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 7:18 AM UTC
| NCT Number | NCT06193486 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Castration-resistant Prostate Cancer |
| Phase | PHASE1 |
| Target Enrollment | 30 participants |
| Active Locations | 1 sites in the US |
| Sponsor | H. Lee Moffitt Cancer Center and Research Institute |
| Last Updated on CT.gov | March 31, 2026 (Mar 31, 2026) |
As of July 17, 2026: Clinical trial NCT06193486 is currently recruiting participants. This phase1 study for metastatic castration-resistant prostate cancer is actively seeking new participants at 1 location across the United States. The study is sponsored by H. Lee Moffitt Cancer Center and Research Institute. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06193486 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06193486 was last updated Mar 31, 2026 (March 31, 2026). HelloStudys verifies this status automatically.